The company has secured partnerships with leading research institutions and has shown promising preclinical results.
Founders
John Doe, Jane Smith
Company Description
Alchemab Therapeutics is focused on harnessing the power of the immune system to develop novel therapeutics for cancer and other diseases. The company utilizes advanced technologies to identify and validate new therapeutic targets.